MYLAN 507 (Hydrochlorothiazide and methyldopa 15 mg / 250 mg)
Pill imprint MYLAN 507 has been identified as Hydrochlorothiazide and methyldopa 15 mg / 250 mg.
Hydrochlorothiazide/methyldopa is used in the treatment of high blood pressure and belongs to the drug class antiadrenergic agents (central) with thiazides. Risk cannot be ruled out during pregnancy. Hydrochlorothiazide/methyldopa 15 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- MYLAN 507
- 15 mg / 250 mg
- 11.00 mm
- Prescription only
- Drug Class:
- Antiadrenergic agents (central) with thiazides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Yellow No. 6
sodium lauryl sulfate
More about hydrochlorothiazide/methyldopa
- Hydrochlorothiazide and methyldopa
- Methyldopa and hydrochlorothiazide (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.